Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cancer Vaccines01:30

Cancer Vaccines

325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytokine co-presentation on targeted lipid nanoparticles enhances in vivo T cell engineering.

Biomaterials·2026
Same author

Functional Annotation of FD Cluster Phage Bouclier that Infects <i>Arthrobacter globiformis</i>.

microPublication biology·2026
Same author

Oversimplified immunology is holding biomaterials back.

Nature reviews bioengineering·2026
Same author

Lipid nanoparticle composition directs systemic trafficking and tissue-specific T cell immunity after intramuscular injection.

Nature biomedical engineering·2026
Same author

Engineering age-adaptive mRNA lipid nanoparticle cancer vaccines via reprogramming systemic gene expression.

bioRxiv : the preprint server for biology·2026
Same author

Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the <i>in vivo</i> persistence of regulatory T cells.

Frontiers in immunology·2026

Related Experiment Video

Updated: May 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

IL-7 Immunotherapies: Current Applications and Engineering Opportunities.

Emily Ariail1,2,3,4, Benjamin Biggs1,2,4, Rowan O'Flanagan3,5

  • 1Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Immunological Investigations
|February 21, 2025
PubMed
Summary

Interleukin-7 (IL-7) is a cytokine crucial for immune cell development and has shown promise in immunotherapy. Engineering IL-7 enhances its therapeutic potential for various clinical applications.

Keywords:
CytokineIL-7engineeringimmunotherapy

More Related Videos

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1&#945; Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.0K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

14.7K

Related Experiment Videos

Last Updated: May 27, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1&#945; Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.0K
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

14.7K

Area of Science:

  • Immunology
  • Biotechnology
  • Therapeutics

Background:

  • Interleukin-7 (IL-7) is a vital cytokine regulating immune cell development and proliferation.
  • IL-7 is essential for T cell, B cell, natural killer cell, and dendritic cell function.
  • Its significant biological activity positions IL-7 as a promising immunotherapy candidate.

Purpose of the Study:

  • To review the physiological functions of IL-7.
  • To explore current therapeutic applications of IL-7.
  • To investigate methods for engineering IL-7 to improve its therapeutic efficacy.

Main Methods:

  • Comprehensive literature review.
  • Analysis of IL-7's physiological role.
  • Investigation of IL-7 engineering strategies.

Main Results:

  • IL-7 demonstrates efficacy in adoptive cell therapy and as a vaccine adjuvant.
  • IL-7 has been utilized in treating sepsis and chronic infections.
  • Engineered IL-7 therapeutics enhance pharmacokinetic and immunological properties, reducing off-target effects.

Conclusions:

  • IL-7 immunotherapies are primarily in the preclinical stage.
  • There is increasing interest in IL-7's therapeutic applications.
  • Further engineering of IL-7 holds potential for clinical translation.